PLANTS, THEIR PROPERTIES, YOUR BALANCE.
Botanical photograph: Blue-leaved mallee (Eucalyptus polybractea R.T.Baker)

BOTANICAL PHOTOGRAPH · FAMILY NOT DETAILED IN THE REFERENCES FOR THIS PROFILE.

THE HERBARIUM · FAMILY NOT DETAILED IN THE REFERENCES FOR THIS PROFILE.

Blue-leaved mallee

Eucalyptus polybractea R.T.Baker

Documented uses
  • Cough associated with a cold and localized muscle painTraditional use
Plant partEssential oil distilled from the leaves
FormsPreparation for inhalation · Topical preparation

Do not swallow the essential oil or apply it to a young child's face.

Identity & origin

BOTANICAL IDENTITY

The right name is the first step.

The shared “eucalypti aetheroleum” monograph includes Eucalyptus polybractea R.T.Baker. This entry is limited to the parts and preparations described in it.

Part used
Essential oil distilled from the leaves
Origin & distribution
Geographical distribution is not detailed in this entry.

The shared monograph concerns an oil of defined quality, not infusions of these two species.

Also known as: No synonyms listed.

This entry does not reproduce the Eucalyptus globulus leaf monograph: another species does not constitute an equivalent herbal tea.

An illustration is not enough to identify a plant for consumption. Do not forage for a species based solely on this profile.

Uses & evidence

UNDERSTANDING THE USES

Properties & uses.

Traditional use

Cough associated with a cold and localized muscle pain

Use of the monographed group; the source does not demonstrate a benefit specific to each species.

Use considered plausible in a traditional-use monograph. That status alone does not demonstrate clinical efficacy.

Read the source

The traditional uses described are not clinical proof of effectiveness. Evidence for one preparation cannot automatically be applied to another.

Precautions before use

BEFORE ANY USE

Precautions & contraindications.

This guidance does not cover every individual situation. Missing information is not a guarantee of safety.

Contraindications & precautions

  • Insufficient dataFull documentary reassessment is incomplete: the existing information is not a guarantee of no risk. Ask a pharmacist to check the preparation and medicines.

Medicine interactions

  • Insufficient dataFull documentary reassessment is incomplete: the existing information is not a guarantee of no risk. Ask a pharmacist to check the preparation and medicines.
Other retained warnings · review incomplete

These existing warnings remain relevant to consult. Their exhaustive reassessment is outside this targeted review.

Restrictions and precautions

  • Allergy to eucalyptus oil or 1,8-cineole.
  • Contraindicated under 24 months and in children with a history of seizures.

Medicine interactions

  • The selected data do not allow compatibility with your treatments to be guaranteed. Ask a pharmacist to check.

Pregnancy, breastfeeding and children

Pregnancy and breastfeeding: medicinal use is not recommended; insufficient data.

Inhaled and topical use is not recommended from age 2 to under 3; oral use is not recommended under 12. Ask a pharmacist to check the exact product.

“Reported” does not prove causality; “possible” may reflect indirect evidence. “None reported” means none in the cited source, not that all combinations have been studied. Do not stop a prescribed treatment based on this profile.

Adverse effects

  • Allergic reactions, sometimes severe; contact eczema may occur.

Pregnancy & breastfeeding

Full documentary reassessment is incomplete: the existing information is not a guarantee of no risk. Ask a pharmacist to check the preparation and medicines.

Children & adolescents

Full documentary reassessment is incomplete: the existing information is not a guarantee of no risk. Ask a pharmacist to check the preparation and medicines.

If symptoms persist, worsen or are unusual, consult a healthcare professional. In an emergency, contact the emergency services.

Forms & how they are used

DOCUMENTED FORMS

One plant, several preparations.

Only forms documented in this profile’s sources are presented.

Preparation for inhalationEssential oil · Route: inhaled

Preparation described in the shared monograph.

Please note: Use a product intended for this route; beware of steam burns. Do not improvise concentrated mixtures.

Read the source
Topical preparationEssential oil · Route: topical

Preparation described in the shared monograph.

Please note: Follow the leaflet; avoid broken or irritated skin and eye contact.

Read the source
Understanding the plant’s actions

EXPLORE THE EVIDENCE

How does the plant act?

Eucalyptus polybractea is a possible source of the eucalyptus essential oil covered by the monograph. This profile therefore does not concern an infusion of its leaves. The assessment covers an oil of defined composition, not every distilled product simply bearing this botanical name.

Constituents to know.

Their presence and quantity depend on the plant part and preparation.

1,8-cineole
Major constituent of the monographed oil. Research on this isolated molecule does not, on its own, demonstrate the efficacy of the whole oil.Read the reference
Traditional use

Respiratory and muscle comfort

The uses remain traditional, with distinct routes and preparations. Local application does not demonstrate systemic action.

Use considered plausible in a traditional-use monograph. That status alone does not demonstrate clinical efficacy.

Read the reference

What this means for preparation.

Look for the oil’s name, intended use and package leaflet. An oil for inhalation or application does not become a product for swallowing; no home ingestion is proposed.

Studies, findings & limitations

THE RESEARCH

What the research shows.

A laboratory or animal result alone does not demonstrate a benefit in humans. Each result must be read alongside the preparation studied and its limitations.

01Insufficient evidence

Isolated molecule or whole oil

The references do not establish a benefit. Lack of evidence is not assurance of safety.

Type of research
Clinical assessment by the EMA
Preparation concerned
Respiratory studies notably on 1,8-cineole, distinct from the complete essential oil.
Observed results
Some symptoms improved, but EMA could not draw a firm conclusion for the whole oil.
Limitations to consider
No separate benefit of this species is established by these data.
Read the reference

What can we take from this?

Fragrance and cineole content guarantee neither respiratory tolerability nor effectiveness. Paediatric restrictions and a history of seizures require specific vigilance.

Documentary review dated 09/10/2026. The references remain available to check the context.

Sources & last review

CHECKING REFERENCES

Sources for this profile.

  1. EMA — eucalypti aetheroleumAccessed on 09/10/2026
  2. EMA — Eucalypti aetheroleum, final revision 1 (20 November 2024)Accessed on 09/10/2026
  3. ANSES — synthèse juin2023, compléments alimentairesAccessed on 09/10/2026

Image: Nina Kerr · CC BY 4.0. View the original image and its licence. Image resized and converted to WebP.

Looking for personal guidance?View consultations · from $40 USD

CONTINUE EXPLORING

More pages to explore.

The full herbarium
Lamiaceae
Use profile

Thymus vulgaris L.

Common thyme

Productive cough associated with a cold

Traditional use

Shortness of breath, fever, purulent sputum, worsening symptoms or symptoms lasting more than a week: seek medical advice.

View the profile
WhatsApp Appointments